M.D. Sass, LLC

Q4 2018 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Bobby Liu - Chief Operating Officer and General Counsel
Location
New York
Holdings as of
31 Dec 2018
Value $
$588,873,000
Num holdings
49
Filing time
30 Jan 2020, 13:58:23 UTC
Form type
13F-HR/A-1 - Restatement
Description
All US holdings of this investor are reported in this report. Top holdings included NRG, GIL, SABR, CMCSA, and LKQ.
Previous filing
Q3 2018 - 30 Jan 2020
Next filing
Q1 2019 - 30 Jan 2020
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2018 Q4 - Restatement compared to 2018 Q3 - Restatement by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Bobby Liu Chief Operating Officer and General Counsel New York, New York 30 Jan 2020

Other Included Managers (2):

Num Name Location File Number
1 M.D. Sass Associates, Inc. New York, NY 028-12005
2 M.D. Sass, LLC New York, NY 028-16534